Biogen to Acquire Apellis for $5.6 billion, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease
On Mar. 31, 2026, Biogen and Apellis Pharmaceuticals announced the companies have entered into a definitive agreement under…
On Mar. 31, 2026, Biogen and Apellis Pharmaceuticals announced the companies have entered into a definitive agreement under…
On Mar. 31, 2026, Eli Lilly and Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines…
On Mar. 20, 2026, the South China Morning Post reported that celebrated scientist Shu Xiaokun, Ph.D. leaves prestigious…
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
On Mar. 12, 2026, scientists at the University of Cambridge announced they have developed a new way to…
On Mar. 12, 2026, Mass General Brigham (MGB) announced it has received a $50 million gift that will…
On Jan. 14, 2026, U.S. healthcare spending rose by 7.2% to $5.3 trillion in 2024 from $4.9 trillion…
On Jan. 13, 2026, The American Cancer Society (ACS) released Cancer Statistics, 2026, the organization’s annual report on cancer facts and trends. The findings show, for…
On Dec. 19, 2025, Novartis, a leading global innovative medicines company, announced it has reached an agreement with…
On Dec. 9, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved the…
On Dec. 2, 2025, findings in the latest Global Burden of Disease 2023 study published in The Lancet…
On Dec. 1, 2025, in an unusual act of philanthropy, an anonymous donor has committed more than $50…
On Nov. 25, 2025, a team of Massachusetts Institute of Technology scientists reported that AI model BoltzGen generates…
On Nov. 25, 2025, Governor Kathy Hochul announced the University at Buffalo (UB) will receive $50 million from…
On Nov. 21, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced it has instructed staffers…
On Nov. 13, 2025, the U.S. Food and Drug Administration (FDA) approved multiple denosumab biosimilars, enhancing market access…
On Nov. 6, 2025, Eli Lilly announced an agreement with the U.S. government to expand access to its…
On Oct. 29, 2025, the U.S. Food and Drug Administration (FDA) announced it is aiming to reduce the…
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
On Oct. 16, 2025, the Food and Drug Administration (FDA) announced the first round of experimental drugs that…
On Oct. 14, 2025, researchers Texas A&M University School of Engineering Medicine (EnMed) announced development of a portable…
On Oct. 10, 2025, AstraZeneca announced a historic agreement with President Donald J. Trump’s administration to lower the…
On Oct. 10, 2025, Ypsomed announced it will establish its first manufacturing facility in the United States. The…
On Sept. 25, 2025, the operator of Pacific Northwest National Laboratory laid off 68 employees effective November 18, saying “unforeseen business circumstances” meant it wasn’t able to provide…
On Sept. 15, 2025, the University of Alberta (U of A) announced the Dianne and Irving Kipnes Health…
On Aug. 25, 2025, MannKind and scPharmaceuticals announced the signing of a definitive merger agreement for MannKind to…
On Aug. 21, 2025, the Mississippi State Department of Health (MSDH) declared a public health emergency in response…
On Aug. 18, 2025, Novo Nordisk announced the launch of a new offer that enables self-paying, eligible, type…
On Aug. 14, 2025, Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines…
On Aug. 7, 2025, research scientists at Scripps Research announced a new platform that enables fast, scalable protein…